Article Information
History
- September 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David Pattinsona,†,
- Peter Jestera,†,
- Lizheng Guana,†,
- Seiya Yamayoshib,c,†,
- Shiho Chibaa,
- Robert Presler Jr.a,
- Hongyu Raoa,
- Kiyoko Iwatsuki-Horimotob,
- Nobuhiro Ikedad,
- Masao Hagiharae,
- Tomoyuki Uchidae,
- Keiko Mitamuraf,
- Peter Halfmanna,
- Gabriele Neumanna and
- Yoshihiro Kawaokaa,b,g,*
- aDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, USA
- bDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Japan
- cThe Research Center for Global Viral Diseases, Research Institute, National Center for Global Health and Medicine, Japan
- dDepartment of General Internal Medicine, Eiju General Hospital, Japan
- eDepartment of Hematology, Eiju General Hospital, Japan
- fDivision of Infection Control, Eiju General Hospital, Japan
- gDepartment of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Japan
- ↵*To whom correspondence should be addressed. Email: yoshihiro.kawaoka{at}wisc.edu. Postal address: Influenza Research Institute, 575 Science Dr, Madison, WI, 53711, USA. Telephone: +1 608 265 4925.
↵† These authors contributed equally to this work.
Posted September 21, 2021.
A method to reduce ELISA serial dilution assay workload applied to SARS-CoV-2 and seasonal HCoVs
